La cadena de opciones muestra datos clave de las opciones de acciones de CareCloud a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para CareCloud..

CareCloud (NASDAQ:CCLD) Bolsa, Cadena de Opciones

CARECLOUD INC

CareCloud

CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

CareCloud Inc

CareCloud, Inc. - 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock

CareCloud Inc 11 % Cum Red Perp Pfd Registered Shs Series -A-

Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) slashed its 2025 sales forecast Wednesday, citing lower-than-expected penetration of its branded GLP-1 weight loss and diabetes treatments in the U.S. market due to competition from compounded versions of the drugs.
What Happened: The Danish pharmaceutical giant now expects sales growth of 13-21% at constant exchange rates, down from previous projections. Operating profit growth is now forecast at 16-24%.
&#8220;We have reduced our full-year outlook due to lower-than-planned branded GLP-1 penetration, which is impacted by the rapid expansion of compounding in the U.S.,&#8221; said CEO Lars Fruergaard Jørgensen in the company&#8217;s first quarter earnings report.
See Also: <a href="https://www.benzinga.com/markets/equities/25/05/45244733/elon-musks-xai-teams-up-with-palantir-twg-global-as-alex-karp-backs-ai-push-in-financial-services">Elon Musk&#8217;s xAI Teams Up With Palantir, TWG Global As Alex Karp Backs AI Push In Financial Services</a>
Why It Matters: The headwinds come as weight-loss industry pioneer WW International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>), formerly known as WeightWatchers, filed for <a href="https://www.benzinga.com/markets/25/05/45243206/despite-bruce-galloways-pushback-on-bankruptcy-weightwatchers-enters-chapter-11-says-members-wont-be-affected">Chapter 11 bankruptcy protection this week</a>, highlighting the disruptive impact of GLP-1 drugs like Novo&#8217;s Wegovy and Ozempic.
Novo Nordisk faces additional market uncertainty as the President Donald Trump administration contemplates policies to match U.S. drug prices with <a href="https://www.benzinga.com/markets/25/04/44945973/trump-administration-considers-lowering-us-drug-prices-to-international-levels-report">lower rates in other developed nations</a>. 
The company continues to expand its product pipeline, recently completing the REDEFINE 2 trial for CagriSema, which demonstrated 15.7% weight loss in adults with obesity or overweight and type 2 diabetes. Novo Nordisk still expects to file for regulatory approval in the first quarter of 2026.
&#8220;With around 1 billion people living with obesity globally and only few million on treatment, Novo Nordisk continues the global roll-out of Wegovy,&#8221; the company stated.
Price Action: Novo Nordisk stock closed at $66.29 on Tuesday, down 4.09% for the day. In after-hours trading, the stock rose 1.37% to $67.20. Year to date, the stock has declined by 24.26%, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">Scott Bessent To Meet Chinese Officials For Crucial Trade Talks In Switzerland: Trump Administration</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: JHVEPhoto / Shutterstock.com

Equities

Health Care

Novo Nordisk's Weight Loss Blockbuster Faces Setback From US Compounding Surge, Forecast Trimmed

Greenfire Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFR#NYSE">GFR</a>) reported quarterly earnings of $0.16 per share. This is a 132 percent increase over losses of $(0.50) per share from the same period last year. The company reported $126.83 million in sales this quarter. This is a 14.95 percent decrease over sales of $149.12 million the same period last year.

Earnings

Greenfire Resources Q1 EPS $0.16 Up From $(0.50) YoY, Sales $126.83M Down From $149.12M YoY

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects The Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) to report quarterly earnings at $1.20 per share on revenue of $23.14 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Disney shares rose 0.8% to $92.92 in after-hours trading.</li>
<li>Analysts are expecting Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) to post quarterly earnings at 50 cents per share on revenue of $11.62 billion. The company will release earnings before the markets open. Uber shares gained 0.8% to $86.47 in after-hours trading.</li>
<li>Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) reported stronger-than-expected first-quarter financial results Tuesday after the bell. AMD said it expects second-quarter revenue of approximately $7.4 billion, plus or minus $300 million. Analysts are currently forecasting second-quarter revenue of $7.24 billion. AMD shares gained 1.8% to $100.40 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Arista Networks Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) posted mixed first-quarter results after Tuesday&#8217;s closing bell. Arista Networks reported quarterly earnings of 65 cents per share, which beat the analyst consensus estimate of 60 cents. Quarterly revenue came in at $2 billion, which missed the consensus estimate of $2.02 billion. The company also said it sees second-quarter revenue of $2.1 billion, versus the $2.11 billion estimate. Arista Networks shares dipped 3.8% to $87.30 in the after-hours trading session.</li>
<li>Analysts expect Owens Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) to post quarterly earnings at $2.87 per share on revenue of $2.51 billion before the opening bell. Owens Corning shares gained 3.7% to $147.88 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo courtesy: DenPhotos / Shutterstock.com

ANET

UBER

Walt Disney, Uber Technologies And 3 Stocks To Watch Heading Into Wednesday

Osisko Development (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ODV#NYSE">ODV</a>) reported quarterly losses of $(0.19) per share. This is a 108.89 percent decrease over losses of $(0.09) per share from the same period last year.

Osisko Development Q1 EPS $(0.19) Down From $(0.09) YoY

The thought of selling Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) makes you feel squeamish? Strike, a cryptocurrency payments firm, has launched a new lending product that allows users to take out loans using the world's largest cryptocurrency as collateral.
What Happened: The firm's CEO, Jack Mallers, took to X, explaining how the new offering would work.
Like other credit-financing mechanisms, Bitcoin-backed loans involve temporarily pledging held BTC as secure collateral and receiving a cash loan, to be repaid with interest. The larger the loan, the more collateral is required.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Announcing Strike Lending You shouldn't have to sell the best-performing asset in human history to access cash. Now you don&#39;t have to. Access your bitcoin wealth without selling it. Build a better life on top of bitcoin with <a href="https://twitter.com/Strike?ref_src=twsrc%5Etfw">@Strike</a>. Borrow fiat. HODL <a href="https://twitter.com/hashtag/bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#bitcoin</a>. <a href="https://t.co/t3SqVeu8fq">pic.twitter.com/t3SqVeu8fq</a>
&mdash; Jack Mallers (@jackmallers) <a href="https://twitter.com/jackmallers/status/1919774506261909705?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
For a 12-month loan, the interest rates begin at 12%, with a minimum borrowing amount of $75,000 and a maximum of $2 million. The loan-to-value ratio will be set at 50%, suggesting that the loans will be overcollateralized.
Strike cautioned that due to Bitcoin's price volatility, the collateral value could diminish, limiting the lender's ability to recover funds. In the event of a liquidation, the collateral could be sold to meet the loan-to-value ratio requirement.
Strive said the feature is available in select U.S. states with plans of expansion in the future.
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/05/45213365/maxine-waters-to-obstruct-cryptocurrency-hearing-plans-shadow-hearing-instead">Maxine Waters Plans Walkout From Crypto Hearing, Will Host &#8216;Shadow Hearing&#8217; Opposing Trump Family Ventures: Report</a>
Why It Matters: Strike was not the first mainstream trading app allowing users to borrow against their Bitcoin holdings. Cryptocurrency behemoth Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)<a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43028215/coinbase-launches-bitcoin-backed-loans-for-us-users"> launched</a> a similar offering earlier in January.
Additionally, decentralized lending protocol Aave (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/aave/usd">AAVE</a>) allows users to access liquidity by supplying their Bitcoin.
Price Action:  At the time of writing, Bitcoin was exchanging hands at $96,666.47, up 2.42% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Photo Courtesy: PV productions On Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45214067/two-dormant-bitcoin-whales-move-325-million-after-a-decade-whats-going-on">Two Dormant Bitcoin Whales Move $325 Million After A Decade: What&#8217;s Going On?</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$AAVE

$BTC

COIN

Have Bitcoin? Need Cash? Strike Launches New Product Allowing Users To Borrow Up To $2 Million

Despite ongoing trade tensions between the U.S. and China, expert quotes the prevailing consensus that is anticipating minimal impact on future economic growth and corporate earnings.
What Happened: This comes after the U.S. and China agreed to hold <a href="https://www.benzinga.com/25/05/45242461/donald-trumps-trade-war-sparks-first-major-us-china-talks-scott-bessent-jamieson-greer-to-meet-chinese-delegation-in-geneva">high-level trade talks</a> in Switzerland this weekend, their first major meeting since President Donald Trump initiated the trade war. The meeting comes amid growing U.S. market concerns over tariff impacts.
According to a recent analysis shared by market strategist Bob Elliott, the current market sentiment is discounting the potential effect of the existing trade policies.
Elliott highlighted that equity analysts and economists appear confident that the &#8220;admin&#8217;s policies&#8221; will not impede earnings growth in the coming years, with earnings projections for 2025 mirroring those of 2024 and even accelerating into 2026.
He underscores the relatively high 12-month forward earnings estimates, which remain considerably above current-year figures, suggesting a lack of widespread concern about long-term repercussions.
While the economic growth forecasts for 2025 have seen some downward revisions, the implied growth for the remainder of the year remains robust. Household consumption growth estimates also remain strong, mirroring the growth seen in the first quarter, as highlighted by Elliott in a series of posts.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Equity analysts continue remain confident that any impacts from the admin&#39;s policies will not result in a drag on earnings ahead. Earnings growth expectations for &#39;25 match that of &#39;24 despite a much different policy environment. And are expected to accelerate to 13% in &#39;26. <a href="https://t.co/WM3iJknf5m">pic.twitter.com/WM3iJknf5m</a>
&mdash; Bob Elliott (@BobEUnlimited) <a href="https://twitter.com/BobEUnlimited/status/1919704301057855788?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45218040/warren-buffett-expresses-disappointment-over-dollar-depreciation-dont-want-to-own-assets-in-a-currency-that-is-really-going-to-hell">Warren Buffett Expresses Disappointment Over Dollar Depreciation: Don&#8217;t Want To Own Assets In A Currency That Is &#8216;Really Going To Hell&#8217;</a>
Why It Matters: Adding a layer of cautious perspective, Marko Kolanovic, former Chief Strategist at JP Morgan, also commented on the news of potential U.S.-China negotiations.
In a social media post, Kolanovic warned against premature optimism concerning the nature of other geopolitical conflicts. He suggested that the initial contact between the two economic powerhouses should not be interpreted as an end to the trade war, highlighting the potentially lengthy and complex nature of such negotiations.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">To think that this very first contact means an end to trade war, would be as naive as to think that the first negotiation between Russia and Ukraine, or Israel and hamas few years ago meant imminent end of the war back then. It didn&#39;t.
&mdash; Marko Kolanovic (@markoinny) <a href="https://twitter.com/markoinny/status/1919879316331970612?ref_src=twsrc%5Etfw">May 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: After Tuesday, the S&amp;P 500 index was out of the correction zone, just down 8.79% from its record high of 6,147.43 points, scaled on Feb. 19. Dow Jones was 9.42% lower than its 52-week high of 45,073.63 points and Nasdaq 100 was 10.94% lower than its previous high of 22,222.61 points.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Tuesday. The SPY was down 0.84% to $558.80, while the QQQ declined 0.93% to $481.41, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Wednesday, the futures of Dow Jones, S&amp;P 500, and Nasdaq 100 were trading higher.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/futures/25/05/45220427/cathie-wood-bucks-consensus-predicts-economic-boom-and-broad-bull-market-the-opportunity-is-now">Cathie Wood Bucks Consensus, Predicts Economic Boom And Broad Bull Market: &#8216;The Opportunity Is Now&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Global

Economics

Trade War Will Not Impact 'Growth Or Earnings Ahead,' Says Expert As China-US Hint At Initiating Negotiations

Reported Earlier, NOVAGOLD Announces Proposed Public Offering Of Up To 43.5M Common Shares

The Company intends to apply to list the Notes on the New York Stock Exchange ("NYSE") and, if the application is approved, expects trading in the Notes on NYSE to begin within 30 days after the Notes are first issued.

Reported Earlier, TWO Harbors Investment Prices $100M Public Offering Of 9.375% Senior Notes Due 2030

The U.K. and India have concluded a free trade agreement after three years of intermittent negotiations, with the aim of boosting bilateral trade by $34 billion by 2040.
What Happened:&nbsp;The deal between the world&#8217;s fifth and sixth largest economies comes in the wake of tariff chaos sparked by U.S. President Donald Trump. The agreement is anticipated to reduce&nbsp;tariffs on goods such as&nbsp;whisky and create opportunities for British companies in India and Indian workers in the U.K, reported Reuters.
Indian Prime Minister&nbsp;Narendra Modi&nbsp;characterized the deal as &#8220;ambitious and mutually beneficial,&#8221; while British Prime Minister&nbsp;Sir Keir Starmer&nbsp;praised it as a &#8220;new era for trade.&#8221;
This deal marks India&#8217;s step towards liberalizing its traditionally protected markets, including the automotive sector, and sets a benchmark for its future interactions with major Western powers. For the U.K., this is the most substantial trade agreement since its exit from the European Union in 2020.
India&#8217;s trade ministry announced that under the agreement, 99% of Indian exports—including textiles—will be exempt from duties. In contrast, the U.K. will see tariff reductions on 90% of its tariff lines.
The deal is expected to boost the UK's annual economic output by £4.8 billion ($6.41 billion) by 2040—a modest yet significant gain relative to the country's £2.6 trillion ($3.47 trillion) GDP in 2024.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/events/25/04/44971154/trump-fails-to-impress-americas-young-shows-poll-as-they-still-favor-biden-only-15-think-us-on-right-track" target="_blank" rel="noreferrer noopener">Trump Fails To Impress America&#8217;s Young, Shows Poll As They Still Favor Biden — Only 15% Think US On Right Track &#8211; Benzinga</a>
Why It Matters:&nbsp;Interestingly, the landmark deal between the U.K. and India comes at a time when a concrete deal between the U.S. and India is highly awaited. 
A few weeks back, U.S. Vice President JD Vance visited India, wherein he finalized terms for a trade negotiation, aiming to double bilateral trade between the U.S. and India to $500 billion by the end of the decade. Meanwhile, U.S. Treasury Secretary Scott Bessent has reiterated several times that India could be the first country to sign a trade deal with the U.S.
Notably, President Trump told reporters on Tuesday that India has offered to drop all tariffs on American imports. &#8220;They&#8217;ve already agreed. They would have never done that for anybody else but me,&#8221; asserted Trump. 
India, however, has not issued any official statements on the matter, as trade negotiations with the U.S. are still ongoing.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45241770/india-fires-missiles-into-pakistani-territory-trump-hopes-fighting-between-nuclear-rivals-ends-very-quickly" target="_blank" rel="noreferrer noopener">India Fires Missiles Into Pakistani Territory, Trump Hopes Fighting Between Nuclear Rivals &#8216;Ends Very Quickly&#8217; &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

UK, India Seal $34 Billion Free Trade Deal Amid Tariff Turmoil — As Trump Waits In The Wings

For April 2025, the total number of terminal passengers at GAP's 12 Mexican airports increased by 9.9%, compared to April 2024. Tijuana, Guadalajara, Los Cabos, and Puerto Vallarta airports presented an increase in passenger traffic of 10.0%, 9.0%, 8.7%, and 5.7% respectively, compared to April 2024. On the other hand, Montego Bay presented a decrease in passenger traffic of 1.3%, compared to April 2024.

Reported Earlier, Grupo Aeroportuario del Pacifico April 2025 Passenger Traffic Increased 9.1% Compared To 2024

MPLX

Reported Earlier, I Squared, MPLX, and Enbridge Announce Agreement to Acquire Equity Stakes in Matterhorn Express Pipeline From Ridgemont And Devon Energy

Johnson Controls International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) will release earnings results for the second quarter, before the <a href="https://www.benzinga.com/quote/JCI/earnings">opening bell on Wednesday, May 7.</a>
Analysts expect the Cork, Ireland-based company to report quarterly earnings at 80 cents per share, up from 78 cents per share in the year-ago period. Johnson Controls International projects to report quarterly revenue at $5.66 billion, compared to $6.7 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On March 12, the company's board of directors approved a regular quarterly dividend of 37 cents per share of common stock.
Johnson Controls International shares fell 0.6% to close at $88.81 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/JCI/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Andrew Kaplowitz maintained a Neutral rating and cut the price target from $95 to $85 on April 14, 2025. This analyst has an accuracy rate of 81%.</li>
<li>JP Morgan analyst Stephen Tusa maintained an Overweight rating and cut the price target from $100 to $81 on April 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Barclays analyst Julian Mitchell maintained an Equal-Weight rating and slashed the price target from $88 to $85 on March 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>UBS analyst Amit Mehrotra upgraded the stock from Neutral to Buy and boosted the price target from $90 to $103 on Feb. 10, 2025. This analyst has an accuracy rate of 75%.</li>
<li>RBC Capital analyst Deane Dray maintained a Sector Perform rating and raised the price target from $86 to $93 on Feb. 6, 2025. This analyst has an accuracy rate of 69%.</li>
</ul>
Considering buying JCI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="568" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-1024x568.png" alt="" class="wp-image-904917" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-1024x568.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07031300/image-61.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

Johnson Controls Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

<ul>
<li>Gates Foundation supports Evotec with a $ 2.5 M grant to generate critical data supporting development of next generation tuberculosis drug combinations.</li>
<li>The collaboration continues a successful partnership on evaluating new treatment regimens aimed at reducing treatment duration and overcoming resistance to current therapies.</li>
</ul>

Evotec Secures $2.5M Grant To Generate Critical Data Supporting New TB Regimens

<ul>
<li>DA-1241 Significantly Decreased Plasma ALT levels, with a Mean Reduction of 22.8 U/L After 16 Week-Treatment</li>
<li>Controlled Attenuation Parameter (CAP) Score Improved by 23.0 dB/m, Indicating Reduced Liver Fat Content</li>
<li>Improvement in Systemic Inflammatory and Fibrosis Biomarkers Supports Beneficial Effects on Liver Health</li>
</ul>

MTVA

MetaVia Presents Phase 2a Data at EASL 2025 Showing DA-1241, A GPR119 Agonist, Significantly Lowers ALT And Liver Fat An Presumed MASH Patients

Data highlighted in late-breaker poster presentation shows that imdusiran achieves functional cure in chronic hepatitis B (cHBV) patients when combined with VTP-300 and low dose nivolumab
In a Phase 1a/1b clinical trial, AB-101, an oral PD-L1 inhibitor, has shown to be generally safe and well-tolerated with evidence of high receptor occupancy and no liver dysfunction in cHBV patients

ABUS

Arbutus's Imdusiran Plus VTP-300 And Low-Dose Nivolumab Achieve HBsAg Loss And Seroconversion In cHBV Patients, New Phase 2a Data Reveal At EASL 2025

WKEY

WISeKey And OISTE.ORG Roll Out Post-Quantum Cryptography Root Key, Preparing Critical Systems For The Quantum Computing Era

– 60% of Participants with Prior Fibrate or Obeticholic Acid Treatment Achieve Biochemical Response with Livdelzi –
– New Evidence Supports Livdelzi Delivers Clinically and Statistically Significant Improvements in Pruritus –

GILD

Gilead Showcases Livdelzi's Efficacy And Tolerability In PBC, With 60% Response Rate Among Patients With Prior Fibrate Or OCA Use, At EASL 2025

DoorDash Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) is shifting its focus beyond food delivery, with CEO Tony Xu outlining plans during the company's earnings call to expand more broadly into local commerce through a range of new services and tech innovations.
What Happened: On Tuesday, during the company&#8217;s <a href="https://benzinga.com/news/earnings/25/05/45221705/doordash-is-hungry-for-growth-q1-orders-jump-18-plans-2-big-acquisitions-to-expand-international-presence">first quarter earnings</a> call, Xu spoke of the company&#8217;s goal of &#8220;connecting every local business to every local consumer,&#8221; before outlining how recent product moves, such as the DashPass membership program, the DoubleDash service, and its investments in autonomous deliveries fit into the same.
Xu sees a lot more potential in DashPass, beyond just the free deliveries that DoorDash users have come to expect. He calls it a &#8220;membership to the physical world,&#8221; designed to engage and offer a growing array of local services. &#8220;There would be no other program in which you would have more or gain more utility,&#8221; he says.
See More: <a href="https://www.benzinga.com/markets/25/05/45243129/nvidia-ceo-jensen-huang-says-losing-access-to-chinas-potential-50-billion-ai-market-would-be-a-tremendous-loss">Nvidia CEO Jensen Huang Says Losing Access To China&#8217;s Potential $50 Billion AI Market Would Be A &#8216;Tremendous Loss&#8217;</a>
DoubleDash, which allows users to shop from multiple stores in a single order with no added fees, will soon feature every retail catalog in their respective cities, according to Xu. He, however, adds that &#8220;we're still in the work of just getting the basics right.&#8221;
Xu says DoorDash will be rolling out its autonomous delivery tech in Los Angeles, which it continues to test in other markets. &#8220;You don't need a 4,000-pound vehicle to deliver a one- or two-pound item or package,&#8221; he says, while adding that the first and last &#8220;10 feet problem&#8221; still needs to be solved.
Why It Matters: The company recently entered into hemp-derived <a href="https://benzinga.com/markets/cannabis/25/02/43558897/exclusive-doordash-reveals-why-its-betting-on-thc-cbd-delivery">THC and CBD deliveries</a>, a niche which the company notes has high repeat purchases and basket sizes, since orders are often bundled with alcohol and snacks.
Early this week, the company announced its <a href="https://www.benzinga.com/25/05/45214764/doordash-to-boost-global-presence-with-nearly-39-billion-acquisition-of-uks-deliveroo">intent to acquire</a> European food delivery company, Deliveroo PLC (OTCMKTS:&nbsp;DROOF) in a $3.9 billion deal, which would allow the combined companies to serve 1 billion people across 40 different countries. 
DoorDash is already a dominant player in urban markets. Domino&#8217;s Pizza Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>), which was holding out against delivery services for years, finally made the decision to <a href="https://www.benzinga.com/news/earnings/25/04/45058659/dominos-is-fine-with-doordash-eyes-full-national-rollout-for-q2-ceo-says-pizza-giants-strategy-is-to-meet-customers-where-they-are">join the platform</a>, after realizing the incremental sales it can provide in the face of dropping same-store sales, calling third-party platforms a $1 billion opportunity for the company.
However, DoorDash's use of its dominant position to gain a competitive edge has come under scrutiny. Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), which operates rival platform Uber Eats, has filed a <a href="https://www.benzinga.com/25/02/43764119/uber-files-a-lawsuit-action-against-doordash-over-anticompetitive-conduct-underhanded-tactics-have-cost-uber-millions-of-dollars-in-revenue">lawsuit accusing DoorDash</a> of engaging in anticompetitive conduct for pressuring restaurants into exclusivity contracts. 
During its <a href="https://benzinga.com/news/earnings/25/05/45221705/doordash-is-hungry-for-growth-q1-orders-jump-18-plans-2-big-acquisitions-to-expand-international-presence">first quarter results</a> on Tuesday, DoorDash reported $3.03 billion in revenue, up 21% YoY, but missed top-line estimates at $3.09 billion. It posted a profit of $0.44 per share, ahead of consensus estimates at $0.39 per share.
Price Action: The stock was down 7.44% on Tuesday, following the company&#8217;s miss on revenue estimates, it is now up 0.75% after hours.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="134" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-1024x134.png" alt="" class="wp-image-904763" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-1024x134.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-300x39.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-768x100.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM-1536x200.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07014755/Screenshot-2025-05-07-at-11.17.41-AM.png 1610w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
According to Benzinga&#8217;s Edge Stock Rankings, DoorDash scores well on Momentum and Growth, while showing a favorable price trend in the short, medium, and long terms. For more insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a>.
Photo Courtesy: rblfmr on Shutterstock.com
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45244190/microsoft-faces-fresh-revenue-hit-as-openai-plans-to-reduce-payouts-by-2030-report">OpenAI To Slash Microsoft Revenue Share By 2030: Report</a></li>
</ul>

DASH

DashPass, DoubleDash And Drones:  DoorDash Plans To 'Connect Every Local Business To Every Local Consumer'

Lucid Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) shared a comprehensive list of updates as well as forecasts at the Q1 2025 earnings call with investors.
What Happened: The EV maker announced $235 million in revenue, which, despite being a 36% YoY increase when compared to Q1 2024, was lower than the estimated $246 million. Lucid also announced -$0.20 Earnings Per Share (EPS), beating Wall Street estimates, the company reported at the earnings call on Tuesday evening.
"​​We delivered 3,109 vehicles, up more than 58% year over year and our fifth consecutive quarter of record deliveries," CEO Marc Winterhoff said. Winterhoff also highlighted a 28% YoY increase in production as the company produced 2,212 vehicles.
Lucid also experienced an increase in gross margins for the quarter. "On a GAAP basis, Q1 gross margin was negative 97.2%, up from negative 134.3% in the prior year quarter," Lucid's CFO, Tafiq Boussaid, shared with investors.
He also outlined an 8-15% impact on margins due to the uncertainties raised by U.S. President Donald Trump's tariffs. The company has also set a target of producing 20,000 units in 2025.
The company also shared its plans to develop a mid-size platform slated to enter production in 2026. "We are working right now with a very strong focus on midsize," Winterhoff said in the call.
Why It Matters: The updates outline what was a successful quarter for the company, which also recently <a href="https://www.benzinga.com/news/25/04/44757588/lucid-wins-nikola-bankruptcy-auction-buys-nikola-facilities-for-30-million-to-boost-us-ev-production">acquired some assets</a> from EV Trucking company Nikola Corp, as well as hiring over 300 employees of the company.
Lucid, which is owned by Saudi Arabia's Sovereign Wealth Fund PIF, had also <a href="https://www.benzinga.com/25/04/44626267/lucid-raises-1-billion-in-debt-offering-to-buy-back-2026-notes-and-boost-financial-flexibility">raised over $1 billion </a>via convertible senior notes earlier this year.
Lucid also <a href="https://www.benzinga.com/trading-ideas/technicals/25/05/45234062/rivian-charges-up-lucid-stuck-in-neutral-tesla-rivals-q1-earnings-face-off">partnered up with KAUST</a>, or King Abdullah University of Science and Technology, to develop advanced autonomous driving capabilities as well as AI hardware.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="205" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-1024x205.jpg" alt="" class="wp-image-904796" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-1024x205.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-300x60.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-768x154.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025-1536x307.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07021046/LCID-MAY-7-2025.jpg 1621w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
LCID scores well on the Growth metric and has satisfactory scores on the Momentum and Value metrics. For more such insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/05/45243985/rivian-holds-firm-on-45k-r2-price-despite-tariff-pressures-ceo-rj-scaringe-says-its-important-for-us-as-ev-maker-tops-q1-estimates">Rivian Holds Firm On $45K Price For Upcoming R2 Despite Tariff Pressures: CEO RJ Scaringe Says It&#8217;s &#8216;Important For Us&#8217; As EV Maker Tops Q1 Estimates&nbsp;</a></li>
</ul>
Photo courtesy: Ian Dewar Photography / Shutterstock.com

Tech

LCID

Tesla-Rival Lucid Announces 58% Increase In Deliveries, Plans To Introduce Mid-Size Platform In 2026

The data presented highlight the following: &nbsp;
<ul>
<li>Sustained improvements from baseline in the Unified Wilson Disease Rating Scale ("UWDRS") Part II (patient-reported symptoms) and Part III (clinician-assessed symptoms);</li>
<li>Increased copper mobilization as evidenced by a sustained increase in dNCC (directly measured non-ceruloplasmin-bound copper);</li>
<li>Improvements on the Clinical Global Impression –&nbsp;Improvement ("CGI-I") scale for ALXN1840 compared to standard of care;</li>
<li>Improvement in the New Wilson Index (based on bilirubin, AST, INR, leukocytes, and albumin) for patients treated with ALXN1840;</li>
<li>Higher patient-reported convenience and effectiveness of ALXN1840 compared to standard of care, including those who transitioned from standard of care to ALXN1840 in the extension portion of the Phase 3 clinical trial; and</li>
</ul>

Comments

CareCloud

CareCloud (CCLD) Opciones

CareCloud (NASDAQ:CCLD) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL